MRIs: FDA Asleep at the Wheel
The European Union has restricted the use of MRI contrasting agents. Why hasn’t the FDA? Action Alert! European health authorities have suspended the use of gadolinium contrasting agents in MRI scans due to concern that these acids can accumulate in the brain. A European review committee found convincing evidence of gadolinium accumulating in brain tissue […]